[1]
D. Studziński, “EFFECTIVENESS AND SAFETY OF ANTI-CGRP MONOCLONAL ANTIBODIES FOR MIGRAINE PREVENTION IN REAL-WORLD PRACTICE: A SYSTEMATIC REVIEW”, IJITSS, vol. 2, no. 2(50), May 2026, doi: 10.31435/ijitss.2(50).2026.5396.